Hydra Biosciences Secures $22,000,000 Series D Funding Round

  • Feed Type
  • Date
    1/16/2009
  • Company Name
    Hydra Biosciences
  • Mailing Address
    790 Memorial Drive, off Pleasant Street Cambridge, MA 02139
  • Company Description
    Hydra Biosciences is a biopharmaceutical company developing molecular regeneration medicines, novel cardiovascular therapies and drugs targeting novel ion channels.
  • Website
    http://www.hydrabiosciences.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $22,000,000
  • Transaction Round
    Series D
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    MedImmune Ventures
  • Venture Investor
    Advanced Technology Ventures
  • Venture Investor
    Abingworth Management Inc
  • Venture Investor
    Polaris Venture Partners
  • Venture Investor
    Bioventures Investors
  • Venture Investor
    Biogen Idec Inc.
  • Venture Investor
    Lilly Ventures

By posting a comment, you agree to our terms and conditions.